Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis.

Brelot A, Chakrabarti LA.

J Mol Biol. 2018 Aug 17;430(17):2557-2589. doi: 10.1016/j.jmb.2018.06.027. Epub 2018 Jun 19. Review.


CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers.

Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, Tan LL, Ciacchi L, Reid HH, Rossjohn J, Chakrabarti LA, Gras S.

Sci Immunol. 2018 Jun 8;3(24). pii: eaat0687. doi: 10.1126/sciimmunol.aat0687.


A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers.

Claireaux M, Galperin M, Benati D, Nouël A, Mukhopadhyay M, Klingler J, de Truchis P, Zucman D, Hendou S, Boufassa F, Moog C, Lambotte O, Chakrabarti LA.

MBio. 2018 May 8;9(3). pii: e00317-18. doi: 10.1128/mBio.00317-18.


DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.

Mukhopadhyay M, Galperin M, Patgaonkar M, Vasan S, Ho DD, Nouël A, Claireaux M, Benati D, Lambotte O, Huang Y, Chakrabarti LA.

J Immunol. 2017 Nov 15;199(10):3437-3452. doi: 10.4049/jimmunol.1700953. Epub 2017 Oct 9.


Public T cell receptors confer high-avidity CD4 responses to HIV controllers.

Benati D, Galperin M, Lambotte O, Gras S, Lim A, Mukhopadhyay M, Nouël A, Campbell KA, Lemercier B, Claireaux M, Hendou S, Lechat P, de Truchis P, Boufassa F, Rossjohn J, Delfraissy JF, Arenzana-Seisdedos F, Chakrabarti LA.

J Clin Invest. 2016 Jun 1;126(6):2093-108. doi: 10.1172/JCI83792. Epub 2016 Apr 25.


TCR clonotypes: molecular determinants of T-cell efficacy against HIV.

Lissina A, Chakrabarti LA, Takiguchi M, Appay V.

Curr Opin Virol. 2016 Feb;16:77-85. doi: 10.1016/j.coviro.2016.01.017. Epub 2016 Feb 12. Review.


[IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV].

Chakrabarti LA, Lortholary O.

Med Sci (Paris). 2015 Jan;31(1):53-9. doi: 10.1051/medsci/20153101013. Epub 2015 Feb 6. Review. French.


Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.

Chakrabarti LA, Boucherie C, Bugault F, Cumont MC, Roussillon C, Breton G, Patey O, Chêne G, Richert L, Lortholary O; ANRS 129 BKVIR-CYTOK STUDY GROUP.

AIDS. 2014 Jul 17;28(11):1593-602. doi: 10.1097/QAD.0000000000000311.


Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles.

Granier C, Battivelli E, Lécuroux C, Venet A, Lambotte O, Schmitt-Boulanger M, Delaugerre C, Molina JM, Chakrabarti LA, Clavel F, Hance AJ.

J Virol. 2013 Sep;87(18):10368-80. doi: 10.1128/JVI.01313-13. Epub 2013 Jul 17.


Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia.

Bugault F, Benati D, Mouthon L, Landires I, Rohrlich P, Pestre V, Thèze J, Lortholary O, Chakrabarti LA.

PLoS One. 2013;8(1):e55570. doi: 10.1371/journal.pone.0055570. Epub 2013 Jan 30.


HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Vingert B, Benati D, Lambotte O, de Truchis P, Slama L, Jeannin P, Galperin M, Perez-Patrigeon S, Boufassa F, Kwok WW, Lemaître F, Delfraissy JF, Thèze J, Chakrabarti LA.

J Virol. 2012 Oct;86(19):10661-74. doi: 10.1128/JVI.00056-12. Epub 2012 Jul 25.


HIV controllers: a multifactorial phenotype of spontaneous viral suppression.

Thèze J, Chakrabarti LA, Vingert B, Porichis F, Kaufmann DE.

Clin Immunol. 2011 Oct;141(1):15-30. doi: 10.1016/j.clim.2011.07.007. Epub 2011 Aug 4. Review.


HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization.

Landires I, Bugault F, Lambotte O, de Truchis P, Slama L, Danckaert A, Delfraissy JF, Thèze J, Chakrabarti LA.

AIDS. 2011 Sep 24;25(15):1843-53. doi: 10.1097/QAD.0b013e32834a3678.


Immune mechanisms of HIV control.

Chakrabarti LA, Simon V.

Curr Opin Immunol. 2010 Aug;22(4):488-96. doi: 10.1016/j.coi.2010.06.006. Review.


HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.

Vingert B, Perez-Patrigeon S, Jeannin P, Lambotte O, Boufassa F, Lemaître F, Kwok WW, Theodorou I, Delfraissy JF, Thèze J, Chakrabarti LA; ANRS EP36 HIV Controllers Study Group.

PLoS Pathog. 2010 Feb 26;6(2):e1000780. doi: 10.1371/journal.ppat.1000780.


Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4.

Scott-Algara D, Balabanian K, Chakrabarti LA, Mouthon L, Dromer F, Didier C, Arenzana-Seisdedos F, Lortholary O.

Blood. 2010 May 6;115(18):3708-17. doi: 10.1182/blood-2009-02-202796. Epub 2009 Dec 28.


Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway.

Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, Niel L, Fontanet A, Delfraissy JF, Thèze J, Chakrabarti LA.

J Virol. 2010 Jan;84(1):96-108. doi: 10.1128/JVI.01475-09.


HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression.

Perez-Patrigeon S, Vingert B, Lambotte O, Viard JP, Delfraissy JF, Thèze J, Chakrabarti LA.

AIDS. 2009 Jun 19;23(10):1197-207. doi: 10.1097/QAD.0b013e32832c4b0a.


A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.

Pillet AH, Bugault F, Thèze J, Chakrabarti LA, Rose T.

J Immunol. 2009 May 15;182(10):6267-77. doi: 10.4049/jimmunol.0801933.


Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.

Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, Sinet M, Colle JH, Urrutia A, Scott-Algara D, Boufassa F, Delfraissy JF, Thèze J, Venet A, Chakrabarti LA.

J Virol. 2007 Dec;81(24):13904-15. Epub 2007 Oct 10.


Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.

Sáez-Cirión A, Versmisse P, Truong LX, Chakrabarti LA, Carpentier W, Barré-Sinoussi F, Scott-Algara D, Pancino G.

Retrovirology. 2006 Nov 8;3:81.


CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes.

Balabanian K, Harriague J, Décrion C, Lagane B, Shorte S, Baleux F, Virelizier JL, Arenzana-Seisdedos F, Chakrabarti LA.

J Immunol. 2004 Dec 15;173(12):7150-60.


A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication.

Chakrabarti LA, Metzner KJ, Ivanovic T, Cheng H, Louis-Virelizier J, Connor RI, Cheng-Mayer C.

J Virol. 2003 Jan;77(2):1245-56.


Interaction of HIV-1 integrase with DNA repair protein hRad18.

Mulder LC, Chakrabarti LA, Muesing MA.

J Biol Chem. 2002 Jul 26;277(30):27489-93. Epub 2002 May 16.


A divergent simian immunodeficiency virus from sooty mangabey with an atypical Tat-TAR structure.

Chakrabarti LA, Luckay A, Marx PA.

AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1155-65.


Age-dependent changes in T cell homeostasis and SIV load in sooty mangabeys.

Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, Martin LN, Skulsky E, Ho DD, Cheng-Mayer C, Marx PA.

J Med Primatol. 2000 Aug;29(3-4):158-65.


Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.

Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, Martin LN, Skulsky E, Ho DD, Cheng-Mayer C, Marx PA.

J Virol. 2000 Feb;74(3):1209-23.


Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease.

Rey-Cuillé MA, Berthier JL, Bomsel-Demontoy MC, Chaduc Y, Montagnier L, Hovanessian AG, Chakrabarti LA.

J Virol. 1998 May;72(5):3872-86.

Supplemental Content

Loading ...
Support Center